Fig. 7From: GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways a Frequency in percent of the most significant pathways dysregulated (up- or downregulated) in the two MDS mice models; b Schematic summary of the dysregulated pathways noted in the two MDS mice models. Upregulated pathways (gray boxes), downregulated pathways (white boxes)Back to article page